NOP58 Antibody

What is NOP58 and what is its role in cellular function?

NOP58 (Nucleolar Protein 58) is a core component of the box C/D small nucleolar ribonucleoprotein (snoRNP) complex. This protein plays a critical role in ribosome biogenesis, particularly in pre-18S rRNA processing. The snoRNP core complex consists of NOP58, NOP56, and fibrillin, working together to facilitate proper ribosomal RNA processing and maturation . NOP58 is ubiquitously expressed across many tissue types and is primarily localized in the nucleolus. In humans, the canonical NOP58 protein has a reported length of 529 amino acid residues and a molecular weight of approximately 59.6 kDa . This protein has been extensively studied in yeast (Saccharomyces cerevisiae) where it is required for pre-18S rRNA processing, highlighting its evolutionary conservation and fundamental importance in eukaryotic cells .

What types of NOP58 antibodies are available for research applications?

Researchers have access to several types of NOP58 antibodies, with the most common being rabbit polyclonal antibodies. These antibodies are produced through immunization with specific epitopes or regions of the NOP58 protein. For example, some antibodies recognize epitopes mapping to regions between residues 350 and 400 of human NOP58 , while others are raised against larger segments such as amino acids 279-529 . Both affinity-purified polyclonal antibodies and recombinant antibodies are available, with different specifications for research applications . These antibodies undergo rigorous validation processes to ensure specificity and reproducibility across experimental conditions, making them reliable tools for investigating NOP58 biology .

In which model systems can NOP58 antibodies be utilized?

NOP58 is highly conserved across species, with gene orthologs reported in mouse, rat, bovine, frog, zebrafish, chimpanzee, and chicken . The available antibodies have been tested for reactivity with human samples, and many show cross-reactivity with other mammalian species due to the high sequence conservation of NOP58 . The antibodies have been validated in multiple human cell lines including HeLa, Jurkat, K-562, MCF-7, HEK-293, and U2OS cells . When working with non-human models, it is advisable to perform preliminary validation experiments to confirm cross-reactivity of the selected antibody with your species of interest, as reactivity patterns may vary among different antibody products.

What are the recommended applications for NOP58 antibodies?

NOP58 antibodies have been validated for multiple experimental applications, with detailed protocols available for each technique:

This table summarizes the key applications and recommended conditions based on data from multiple antibody manufacturers . The optimal dilution may vary depending on the specific antibody and experimental conditions, so preliminary titration experiments are recommended.

How should I optimize Western blot protocols for NOP58 detection?

For optimal Western blot detection of NOP58, follow these methodological recommendations:

• Sample preparation: Use standard cell lysis buffers containing protease inhibitors to prevent protein degradation. NOP58 is primarily located in the nucleus/nucleolus, so ensure your extraction method effectively lyses nuclear membranes.

• Protein loading: Load 20-40 μg of total protein per lane for cell lysates. For tissue samples, 50-80 μg may be required for clear detection.

• Gel selection: Use 10% SDS-PAGE gels for optimal resolution of NOP58 (59.6 kDa).

• Transfer conditions: Transfer to PVDF or nitrocellulose membranes at 100V for 1-1.5 hours or overnight at 30V in cold room.

• Blocking: Block membranes with 5% non-fat dry milk in TBST for 1 hour at room temperature .

• Antibody incubation: Dilute primary NOP58 antibody (1:2000-1:10000) in blocking buffer and incubate overnight at 4°C with gentle rocking .

• Detection: Use appropriate HRP-conjugated secondary antibodies (typically anti-rabbit IgG) and enhanced chemiluminescence (ECL) detection reagents.

The expected molecular weight of NOP58 is approximately 60 kDa, which corresponds to the observed molecular weight in validated samples . If detecting post-translationally modified forms of NOP58, additional bands at higher molecular weights may be observed due to sumoylation .

What controls should be included when using NOP58 antibodies?

To ensure experimental rigor and validity of results, the following controls should be included when working with NOP58 antibodies:

• Positive controls: Include lysates from cell lines known to express NOP58, such as HeLa, Jurkat, or HEK-293 cells, which have been validated for NOP58 expression .

• Negative controls:

  • Primary antibody omission control: Incubate samples with secondary antibody only to detect non-specific binding

  • Isotype control: Use a non-specific IgG from the same species as the NOP58 antibody

  • Knockdown/knockout validation: If possible, include samples from NOP58-depleted cells (siRNA knockdown or CRISPR knockout)

• Loading controls: For Western blots, include detection of housekeeping proteins such as GAPDH, β-actin, or nuclear proteins like Lamin B1 (since NOP58 is nuclear).

• Peptide competition assay: Pre-incubate NOP58 antibody with the immunizing peptide to confirm specificity of the observed signal.

These controls help distinguish specific signals from background noise and validate the specificity of the antibody, ensuring robust and reproducible results in your experiments.

Why might I observe multiple bands in Western blot using NOP58 antibodies?

The detection of multiple bands when probing for NOP58 can occur for several reasons:

• Post-translational modifications: NOP58 undergoes sumoylation , which can result in higher molecular weight bands. These modified forms are biologically relevant and may vary between cell types or under different experimental conditions.

• Alternative splicing: While the canonical form of NOP58 is 529 amino acids (59.6 kDa), alternative splice variants may exist that produce proteins of different sizes.

• Proteolytic degradation: Incomplete protease inhibition during sample preparation can lead to protein degradation, resulting in lower molecular weight bands.

• Cross-reactivity: Some antibodies may cross-react with related proteins, particularly NOP56, which shares sequence homology with NOP58, as both are members of the NOP5/NOP56 protein family .

To distinguish between these possibilities, consider the following approaches:

• Compare the observed band pattern across multiple cell lines with known NOP58 expression

• Use different NOP58 antibodies targeting distinct epitopes

• Perform immunoprecipitation followed by mass spectrometry to identify the proteins present in each band

• Include samples with NOP58 knockdown to confirm which bands are specific

Understanding the nature of these multiple bands can provide insights into NOP58 biology and post-translational regulation in your experimental system.

How can I validate the specificity of my NOP58 antibody?

Validating antibody specificity is crucial for generating reliable experimental data. For NOP58 antibodies, consider implementing these validation strategies:

• Genetic approach:

  • RNA interference (siRNA/shRNA) to knockdown NOP58 expression

  • CRISPR-Cas9 mediated knockout of NOP58

  • Compare staining/band intensity between wildtype and knockdown/knockout samples

• Orthogonal detection methods:

  • Use multiple antibodies targeting different epitopes of NOP58

  • Complement antibody-based detection with RNA-level analysis (qPCR, RNA-seq)

  • Express tagged versions of NOP58 (e.g., GFP-NOP58) and compare localization patterns

• Immunoprecipitation-mass spectrometry:

  • Perform IP with the NOP58 antibody followed by mass spectrometry

  • Confirm that NOP58 is the predominant protein identified

• Peptide competition assay:

  • Pre-incubate the antibody with excess immunizing peptide

  • Compare signal between blocked and unblocked antibody conditions

• Cross-species validation:

  • Test reactivity in species with high and low sequence homology to human NOP58

  • Expected reactivity should correlate with sequence conservation

How can NOP58 antibodies be used to study ribosome biogenesis?

NOP58 antibodies offer powerful tools for investigating the complex process of ribosome biogenesis:

• Chromatin Immunoprecipitation (ChIP) assays:

  • Use NOP58 antibodies to perform ChIP at rDNA loci

  • Identify genomic regions bound by NOP58 during ribosome biogenesis

  • Combine with sequencing (ChIP-seq) for genome-wide analysis

• RNA Immunoprecipitation (RIP):

  • Immunoprecipitate NOP58-containing complexes to isolate associated RNAs

  • Identify box C/D snoRNAs and pre-rRNAs interacting with NOP58

  • Assess the impact of cellular stress or drug treatments on these interactions

• Proximity Ligation Assay (PLA):

  • Combine NOP58 antibodies with antibodies against other ribosome biogenesis factors

  • Visualize and quantify protein-protein interactions in situ

  • Map the spatial organization of ribosome assembly complexes

• Immunofluorescence co-localization:

  • Use NOP58 antibodies alongside markers for different nucleolar compartments

  • Track changes in nucleolar organization during cell cycle or stress conditions

  • Quantify co-localization with other snoRNP components like NOP56 and fibrillarin

• Pulse-chase experiments:

  • Combine NOP58 immunoprecipitation with radiolabeled nucleotide incorporation

  • Track the kinetics of ribosome assembly and maturation

  • Identify rate-limiting steps in ribosome biogenesis

These methodologies allow researchers to dissect the molecular mechanisms underlying NOP58's role in ribosome biogenesis, providing insights into fundamental cellular processes and potential disease mechanisms.

What techniques can be used to study NOP58 post-translational modifications?

NOP58 undergoes sumoylation and potentially other post-translational modifications (PTMs) that may regulate its function. The following techniques can be employed to study these modifications:

• PTM-specific antibodies:

  • Use antibodies that specifically recognize sumoylated proteins alongside NOP58 antibodies

  • Perform sequential immunoprecipitation to enrich for modified forms

• Mass spectrometry analysis:

  • Immunoprecipitate NOP58 and analyze by mass spectrometry

  • Identify specific residues modified by sumoylation, phosphorylation, or other PTMs

  • Quantify changes in modification status under different cellular conditions

• In vitro modification assays:

  • Express recombinant NOP58 and incubate with purified enzymes (e.g., SUMO ligases)

  • Use modified proteins as standards for comparison with cellular NOP58

• Site-directed mutagenesis:

  • Generate mutant forms of NOP58 where potential modification sites are altered

  • Express these mutants in cells and assess functional consequences

  • Compare localization, complex formation, and activity of wildtype vs. mutant proteins

• Inhibitor studies:

  • Treat cells with inhibitors of specific PTM pathways (e.g., SUMO pathway inhibitors)

  • Examine changes in NOP58 modification, localization, and function

By combining these approaches, researchers can dissect the complex regulation of NOP58 by post-translational modifications and understand how these modifications influence its role in ribosome biogenesis and other cellular processes.

How to investigate interactions between NOP58 and other snoRNP components?

Investigating the interactions between NOP58 and other components of the box C/D snoRNP complex is crucial for understanding ribosome biogenesis. Here are methodological approaches for studying these interactions:

• Co-immunoprecipitation (Co-IP):

  • Use NOP58 antibodies to pull down associated proteins

  • Detect known partners (NOP56, fibrillarin) by Western blot

  • Identify novel interactors by mass spectrometry

  • For optimal results, use mild lysis conditions to preserve protein complexes

• Proximity-dependent labeling:

  • Express BioID or APEX2 fusions of NOP58 in cells

  • Identify proteins in close proximity to NOP58 through biotinylation

  • Compare interactome under different cellular conditions

• Förster Resonance Energy Transfer (FRET):

  • Tag NOP58 and potential interaction partners with appropriate fluorophores

  • Measure energy transfer as indication of protein-protein proximity

  • Perform live-cell imaging to track dynamic interactions

• Yeast two-hybrid or mammalian two-hybrid:

  • Screen for direct binding partners of NOP58

  • Map interaction domains through truncation or mutation analysis

  • Validate interactions identified through other methods

• Structural studies:

  • Use antibodies to purify native snoRNP complexes for structural analysis

  • Employ cryo-electron microscopy or X-ray crystallography

  • Generate structural models of NOP58 within the context of the snoRNP complex

These methodologies provide complementary approaches to map the interaction network of NOP58, revealing both stable core interactions and dynamic associations that occur during ribosome biogenesis.

What role does NOP58 play in disease pathogenesis?

While primarily known for its role in ribosome biogenesis, emerging research suggests potential links between NOP58 dysregulation and various diseases. Researchers can use NOP58 antibodies to investigate these connections through:

• Expression analysis in disease tissues:

  • Compare NOP58 levels in normal versus diseased tissues using immunohistochemistry

  • Create tissue microarrays to screen multiple samples simultaneously

  • Correlate expression patterns with clinical outcomes

• Cancer research applications:

  • Examine NOP58 expression across cancer types and stages

  • Investigate associations between ribosome biogenesis defects and cancer progression

  • Assess NOP58 as a potential biomarker for certain cancer types

• Neurodegenerative disease studies:

  • Analyze NOP58 localization in brain tissues from patients with neurodegenerative disorders

  • Investigate potential roles in nucleolar stress response pathways

  • Examine interactions with disease-associated proteins

Future investigations may reveal new roles for NOP58 beyond its canonical function in ribosome biogenesis, potentially opening avenues for diagnostic or therapeutic interventions in diseases characterized by nucleolar dysfunction.

What cutting-edge technologies can enhance NOP58 research?

Several emerging technologies can advance our understanding of NOP58 biology:

• CRISPR-based approaches:

  • Generate fluorescently tagged endogenous NOP58 using CRISPR knock-in

  • Perform CRISPR screens to identify genes affecting NOP58 function

  • Use CRISPRi/CRISPRa to modulate NOP58 expression without complete knockout

• Single-cell technologies:

  • Apply single-cell RNA-seq to examine cell-to-cell variability in NOP58 expression

  • Use mass cytometry (CyTOF) with metal-conjugated NOP58 antibodies for high-dimensional analysis

  • Perform single-cell proteomics to analyze NOP58 complex composition in individual cells

• Super-resolution microscopy:

  • Apply techniques like STORM, PALM, or STED using NOP58 antibodies

  • Resolve sub-nucleolar structures and protein distributions at nanometer resolution

  • Track dynamic rearrangements of NOP58-containing complexes

• Mathematical modeling:

  • Develop quantitative models of ribosome biogenesis incorporating NOP58 function

  • Predict system behavior under various perturbations

  • Guide experimental design for testing model predictions

These cutting-edge approaches, combined with well-validated NOP58 antibodies, will enable researchers to address fundamental questions about nucleolar function and ribosome biogenesis with unprecedented resolution and insight.